Publicaciones en colaboración con investigadores/as de University of Copenhagen (23)

2024

  1. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 10, pp. 2648-2668.e2

  2. Effect of lipid-polymer hybrid nanoparticles on the biophysical function and lateral structure of pulmonary surfactant: Mechanistic in vitro studies

    Journal of Colloid and Interface Science, Vol. 654, pp. 1111-1123

  3. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. Insights into the mechanisms of interaction between inhalable lipid-polymer hybrid nanoparticles and pulmonary surfactant

    Journal of Colloid and Interface Science, Vol. 633, pp. 511-525

  2. Munc13- and SNAP25-dependent molecular bridges play a key role in synaptic vesicle priming

    Science Advances, Vol. 9, Núm. 25

  3. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203

2022

  1. Pulmonary surfactant and drug delivery: Vehiculization of a tryptophan-tagged antimicrobial peptide over the air-liquid interfacial highway

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 180, pp. 33-47

  2. Structure of the RAF1-HSP90-CDC37 complex reveals the basis of RAF1 regulation

    Molecular Cell, Vol. 82, Núm. 18, pp. 3438-3452.e8

2021

  1. AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity

    Nature, Vol. 592, Núm. 7856, pp. 799-803

  2. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy

    Clinical and Translational Allergy, Vol. 11, Núm. 4

  3. An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function

    Current Research in Toxicology, Vol. 2, pp. 225-236

  4. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 3, pp. 648-676

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Update of P2Y receptor pharmacology: IUPHAR Review 27

    British Journal of Pharmacology, Vol. 177, Núm. 11, pp. 2413-2433

2019

  1. IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 5, pp. 1418-1429

  2. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

    Allergy: European Journal of Allergy and Clinical Immunology

2017

  1. ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer's disease is restricted to aged animals

    Biomaterials, Vol. 112, pp. 141-152

2016

  1. Aerobic exercise training increases muscle water content in obese middle-age men

    Medicine and Science in Sports and Exercise, Vol. 48, Núm. 5, pp. 822-828

  2. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222